ACADIA Pharmaceuticals Inc. (ACAD)

ACADIA Pharmaceuticals Market Cap

ACADIA Pharmaceuticals has a market cap or net worth of $3.78 billion as of June 22, 2026. Its market cap has increased by 5.91% in one year.

• Market Cap: 3.78B
• Enterprise Value: 2.98B
• 1-Year Change: 5.91%
• Ranking: #1632
• Category: Mid-Cap
• Stock Price: $22.09

Market Cap Chart

Since May 27, 2004, ACADIA Pharmaceuticals's market cap has increased from $112.80M to $3.78B, an increase of 3,253.37%. That is a compound annual growth rate of 17.24%.

Market Cap History

Date	Market Cap	% Change
Jun 22, 2026	3.78B	-16.29%
Dec 31, 2025	4.52B	48.00%
Dec 31, 2024	3.05B	-40.60%
Dec 29, 2023	5.14B	99.41%
Dec 30, 2022	2.58B	-31.29%
Dec 31, 2021	3.75B	-55.85%
Dec 31, 2020	8.50B	28.98%
Dec 31, 2019	6.59B	225.79%
Dec 31, 2018	2.02B	-45.92%
Dec 29, 2017	3.74B	7.07%
Dec 30, 2016	3.49B	-2.91%
Dec 31, 2015	3.60B	13.57%
Dec 31, 2014	3.17B	39.50%
Dec 31, 2013	2.27B	762.44%
Dec 31, 2012	263.30M	361.93%
Dec 30, 2011	57.00M	20.76%
Dec 31, 2010	47.20M	-6.53%
Dec 31, 2009	50.50M	51.20%
Dec 31, 2008	33.40M	-91.84%
Dec 31, 2007	409.20M	56.24%
Dec 29, 2006	261.90M	13.18%
Dec 30, 2005	231.40M	102.63%
Dec 31, 2004	114.20M	1.24%
May 27, 2004	112.80M	-

View and export this data all the way back to 2004. Sign Up Today.

Data Source: Nasdaq Data Link Last updated: Jun 18, 2026

Market cap data is provided by Nasdaq Data Link. The current market cap updates continuously throughout the trading day, while the historical market cap is updated daily after market close.

Update frequency:

Daily

Last checked:

Jun 22, 2026

Data Sources Report a data error

Related Stocks

Company	Market Cap
Tango Therapeutics	4.05B
Edgewise Therapeutics	3.96B
Veradermics	3.92B
Catalyst Pharmaceuticals	3.84B
Crinetics Pharmaceuticals	3.78B
Denali Therapeutics	3.70B
Viking Therapeutics	3.53B
NewAmsterdam Pharma Company	3.49B